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ABSTRACT
Diabetes has been concluded to be a global epidemic (Wild, Sicree, Roger, King
& Green, 2004). By the year 2030, it is predicted that depression will become the second
leading cause of disability worldwide (World Health Organization [WHO], 2007). The
relationship between diabetes and depression is likely not casual.
Those with diabetes are twice as likely to develop depression (Eaton, Armenian,
Gallo, Pratt & Ford, 1996; Kawakami, Shimizu, Takatsuka, & Ishibashi, 1999).
Conversely, diabetes doubles the likelihood of comorbid depression (Anderson, Clouse,
Freedland & Lustman, 2001). The intersection of these two devastating diseases is far
from benign. Black, Markides and Ray (2003) found that overall mortality was increased
five times in those with diabetes who also suffered from depression.
There is a particularly increased burden of depression in elders with diabetes, with
up to 30% of those over age 65 having this dual diagnosis (Anderson et al., 2001).
Despite this high prevalence, depression is underdiagnosed in the elderly, and this group
has a disproportionate rate of suicide. Better strategies are needed for identifying and
treating depression in elders with concomitant diabetes.
The purpose of this study was to assess the prevalence of depression in a
community-dwelling population of elders with type 2 diabetes who were receiving
diabetes self-management education (DSME) services. Specific characteristics of elders
with diabetes were assessed in relationship to depression. A diabetes and depression
survey instrument (DD-S) and a self-administered depression instrument (CES-D) were
v

administered to 153 elderly clients of Humphreys Diabetes Center in Boise, Idaho.
Twenty-six completed surveys were returned by mail.
An extremely high prevalence of depression (46%) was discovered. Most
participants in the depression group were female (88.8%). Four participants in this group
had not been previously diagnosed with depression, and two participants under treatment
for depression were found to have ongoing symptoms. Depression was found to be
significantly associated with the total number of medications participants reported taking.
Individual medical conditions were not associated with being classified in the depression
group nor were complications of diabetes. Depression was not associated with any
specific demographic variable, with diabetes care compliance, or with diabetes control as
measured by HA1c.
It is concluded that elders with diabetes, especially females, are at very high risk
of concomitant depression. Assessment of the total number of medications in elders with
diabetes might help identify a subgroup at particularly high risk for depression. The
findings from this study suggest that the use of the survey tools (DD-S in combination
with the CES-D administered during DSME) may be an effective means of screening for
depression in elders with diabetes.
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CHAPTER I
Introduction
Despite having high rates of suicide, elders with depression are underdiagnosed
and undertreated for this disabling disorder (Centers for Disease Control and Prevention
[CDC] 2007). There is a particularly increased burden of depression in elders with
diabetes, with up to 30% of those over age 65 having this dual diagnosis (Anderson et al.,
2001). A depression diagnosis has been associated with worsening of diabetes control,
increase in diabetes complications and excess mortality (Black et al., 2003). Better
strategies are needed to screen for and treat depression elders with concomitant diabetes.
The elderly are less likely to seek treatment for depression due to the stigma this
age group often associates with having a mental illness (Ayalon, Arean & Alvidrez,
2005). In addition, the elderly have more drug side-effects and are less tolerant of
medical therapy for depression (Borchelt, 1995) than younger patients with diabetes. Risk
factors for depression in this population have not been well-characterized.
This study consisted of a diabetes survey and a depression self-test to examine the
relationship between depression and possible risk factors for depression in elders with
diabetes who were receiving diabetes self-management education (DSME) services at a
community diabetes education center. DSME may represent an ideal opportunity to
screen for depression.
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Statement of the Problem
Elders with diabetes have a high rate of depression compared to younger persons
with diabetes. In this particularly high-risk population, depression is underdiagnosed and
can worsen diabetes control, complications and mortality rates. Better strategies are
needed for identifying depression in elders with diabetes.

Purpose and Significance of the Study
The purpose of this study was to assess the prevalence of depression in a
community-dwelling population of elders with type 2 diabetes receiving diabetes selfmanagement education (DSME). In addition, specific characteristics of elders with
diabetes, which might be associated with depression or depressive symptoms, were
assessed. For example, certain demographic variables or differences in current practice of
diabetes self-management techniques may be associated with the prevalence of
depression in this population. A better understanding of factors associated with
depression in elders with diabetes could lead to improved screening and treatment for this
disabling disorder. Treatment of depression can dramatically improve quality of life for
those with chronic diseases such as diabetes (Jackson, DeZee & Berbano, 2004) and has
recently been shown to decrease overall mortality in those with type 2 diabetes (Bogner,
Morales, Post & Bruce, 2007).

Specific Research Questions
The questions addressed in this study were:
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1. What is the prevalence of depression and/or depressive symptoms in an
elderly community dwelling sample of patients with diabetes receiving DSME
services?
2. Are there particular characteristics of elders with diabetes that place them at
higher risk for developing depression?
3. Will depression screening during DSME identify elders with undiagnosed
depression?

Limitations
The limitations of this study include:
1. The study utilized a nonexperimental, cross-sectional design.
2. A convenience sample was used.
3. Those who attend DSME classes may have a different rate of depression than
those who do not attend DSME classes.
4. Diagnosis of depression and assessment of depressive symptoms were by selfreport and may underestimate the true prevalence.
5. The visually impaired may have had trouble completing the survey and selftest.
6. The study survey has not been validated in previous studies.

Delimitations
There were two major delimitations of this study:
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1. This study was delimited to community-dwelling elders aged 55 and older
with type 2 diabetes receiving DSME services at Humphreys Diabetes Center
(HDC) in Boise, Idaho.
2. The variables of interest in this study were delimited to depression diagnosis
and/or depressive symptoms, and self-reported data including:
sociodemographic information, duration of diabetes, complications of
diabetes, self-care behaviors, comorbidities, and medication use.

Assumptions
The following assumptions were made for this research study:
1. Participants completed the survey and depression self-assessment tool
accurately and honestly.
2. Elders with diabetes receiving DSME services at HDC are representative of
other elders in the community with diabetes.

Hypotheses
This study tested the following null hypotheses:
1. There is not a high prevalence of depression in elders with diabetes.
2. There are no specific characteristics associated with depression in elders with
diabetes.
3. Screening during DSME will not identify elders with undiagnosed depression.
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Definition of Terms
Elderly: for this study, elderly will be considered to be ≥ 55 years of age.
Type 2 diabetes: a condition of chronic carbohydrate intolerance characterized by
elevated blood sugar due to insulin resistance and insulin deficiency.
Insulin: the hormone that allows sugar to be absorbed by cells in the body.
Microvascular: small blood vessel-related.
Macrovascular: large blood vessel-related.
Self-care behaviors: blood sugar self-monitoring, foot checks (checking feet for
signs of infection and/or injury), meal plan adherence and frequency of
exercise.
HA1c: percent of hemoglobin that is glycosylated or attached to sugar. It is an
average measurement of the level of sugar in the blood over a three-month
period.
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CHAPTER II
Literature Review
The purpose of this literature review is to examine the relationship between
diabetes and depression in the elderly. First, the literature on diabetes in the elderly
population will be examined. Second, studies related to depression in the elderly will be
reviewed. Third, the connection between diabetes and depression will be established.
Next, treatment of depression in the elderly will be outlined. Finally, DSME as an
opportunity for depression screening will be explored.

Diabetes in the Elderly
Wild et al. (2004) reviewed the prevalence of diabetes and concluded that
diabetes is a global epidemic. They predicted that the number of people with diabetes will
more than double from 177 million to 366 million from the year 2000 to the year 2030.
One in five adults over the age of 65 has diabetes, and the most significant contribution to
the diabetes epidemic is the increasing number of people over age 65. The Centers for
Disease Control and Prevention (CDC) (2007) support the view of diabetes as an
epidemic and underscore the tremendous impact of this disease.
Diabetes leads to devastating microvascular complications such as blindness,
kidney failure and painful neuropathy, and it is the leading cause of nontraumatic
amputations (American Diabetes Association (ADA), 2008). The macrovascular
complications of diabetes include heart disease, stroke, and peripheral vascular disease
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(Chau, Shumaker & Plodkowski, 2005). All of these complications are exacerbated by
aging (Gregg & Brown, 2003).
The prevalence of diabetes increases dramatically with age, and studies have
confirmed the high burden of diabetes in the elderly. For example, Selvin, Coresh, and
Brancati (2006) analyzed data from 2,809 elderly individuals in the National Health and
Nutrition Examination Survey and found the prevalence of diabetes in adults age 65 or
older to be 15.3%. This is nearly twice the overall prevalence for the disease in the
United States. In another population-based study conducted in Rotterdam, the
Netherlands, oral glucose tolerance tests were administered to 7,439 elderly men and
women age 55 years and older. The overall prevalence of diabetes was estimated to be
11.3%. However, in those age 85 years and older the prevalence was 18.9%. More than
half of those in the study who were found to have diabetes were previously undiagnosed
(Stolk et al., 1997). With those age 85 years and older being the fastest growing segment
of the American population (Hobbs, 2001), the diabetes epidemic is likely to rapidly
intensify.

Depression in the Elderly
Depression is another common affliction of modern society. By the year 2030, it
will become the second leading cause of disability worldwide (WHO, 2007). It engenders
high costs to both the individual in terms of anguish and decreased productivity and
creates a tremendous economic and social loss to society (Simon, 2003). Depression is
underdiagnosed in the elderly, and this group has a disproportionate rate of suicide
(National Institute of Mental Health [NIMH], 2007). Spousal death and chronic illness
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are the two most significant risk factors for the development of geriatric depression
(Shoevers et al., 2006). Other previously identified risk factors include prior depression,
sleep disturbance, disability, and female gender (Cole & Dendukuri, 2003). Risk factors
for depression in elders with diabetes have not specifically been studied.

The Interrelationship of Diabetes and Depression
The relationship between diabetes and depression is likely not casual. Those with
depression are twice as likely to develop diabetes (Eaton et al., 1996; Kawakami et al.,
1999). Conversely, diabetes doubles the likelihood of comorbid depression from 15% to
approximately 30%, according to a comprehensive meta-analysis by Anderson et al.
(2001). Finkelstein et al. (2003), in a retrospective study of over two million Medicare
claimants age 65 and older, found that there was a significantly greater likelihood (OR
1.58±0.05) of depression in those with diabetes than in those who did not have the
disease. A study of depressive symptoms in rural elders in North Carolina with diabetes
revealed a high risk for depressive symptoms, regardless of ethnicity (Bell et al., 2005).
When diabetes and depression intersect, the effect on adverse events appears to be
highly synergistic. Black et al. (2003) examined longitudinal data from the Hispanic
Established Population for the Epidemiologic Study of the Elderly (EPESE) survey and
found that the risk of microvascular complications of diabetes increase eleven-fold. In
addition, macrovascular complications double, and overall mortality increases five times
in those with diabetes who also suffer from depression. Increased mortality was also
strongly associated with both minor and major depression in a large Health Maintenance
Organization (HMO) study of 4,154 patients with type 2 diabetes (Katon et al., 2005).
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DeGroot, Anderson, Freedland, Clouse, and Lustman (2001) conducted a meta-analysis
of 27 studies linking diabetes and depression. A significant association was found
between depression and diabetes complications. In addition, those with both diabetes and
depression were less compliant with treatment and found to have 86% higher health costs
than those with diabetes alone (Ciechanowski, Katon & Russo, 2000).
The dual presence of diabetes and depression has a dramatic effect on quality of
life. More than 3,000 adults in Australia were assessed with the Short Form HealthRelated Quality of Life Questionnaire (SF-36). Those with diabetes and depression
experienced a severe impact, with a large effect size, on every dimension of the SF-36 as
compared to those with diabetes who were not depressed (Goldney, Fisher, Phillips &
Wilson, 2004). Likewise, an SF-36 study in an elderly Greek population with diabetes
found that comorbidity, such as concomitant depression, was a significant predictor of
lower health-related quality of life (Papadopoulos, Kontodimopoulos, Frydas,
Ikonomakis & Niakas, 2007). Several instruments have been developed to assess
diabetes-specific quality of life, and impact on psychological functioning is considered
central to this assessment (Polonsky, 2000).

Treatment of Depression in Elderly Diabetes Patients
Even when depression is properly diagnosed, treatment of depression in the elder
with diabetes is complicated. Physiological changes associated with aging make the
elderly more prone to medication side effects and drug-drug interactions (Hitner &
Nagle, 2005). Ayalon, Arean, and Alvidrez (2005) found significant barriers to treatment
of depression in the elderly that included not only side effects of the medications, but also
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fear of stigma of being treated for depression. Cognitive impairment was associated with
unintentional nonadherence to medication.
Another issue facing elderly persons is the fact that type 2 diabetes has significant
comorbidity with other medical conditions such as hypertension and hyperlipidemia
(Robbins, Webb & Sciamanna, 2005). Almost all patients with type 2 diabetes are
prescribed multiple medications, and adverse drug interaction becomes an increasing
concern (Borchelt, 1995). Patients may not understand that the antidepressant is just as
important as their other medications. Cost is also a huge barrier to treatment of
depression and leads to poor health outcomes (Mojtabal & Olfson, 2003).
Standard antidepressants have been studied in the treatment of depression in those
with diabetes. Nortriptyline, an older, less expensive antidepressant was evaluated in a
double-blind, placebo-controlled trial of 68 patients (Lustman et al., 1997). This drug was
found to be effective for treating depression; however, it had a negative effect on
glycemic control. In addition, nortriptyline, and the older antidepressant drugs in general,
can have substantive anticholinergic side effects (Hitner & Nagle, 2005). Anticholinergic
action has recently been associated with cognitive decline in a longitudinal cohort study
of 372 participants over age 60 (Ancelin et al., 2006). This is an unacceptable outcome of
the treatment of geriatric depression.
Newer antidepressant agents, such as the selective serotonin reuptake inhibitor
(SSRI) fluoxetine, have good efficacy and are less anticholinergic than the older agents
(Lustman, Freedland, Griffith & Clouse, 2000). They do not worsen glycemic control;
however, they are much more costly. No antidepressant drug trials have specifically
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evaluated elders with diabetes and depression, though fluoxetine has been approved for
use in the elderly population.
Second generation antipsychotics are being used more and more frequently as
adjunctive treatment in both unipolar and bipolar depression. Koller, Cross, Doraiswamy,
and Schneider (2003) studied the hyperglycemic effect of the drug respiradone, a secondgeneration antipsychotic agent. They reported that respiradone and several other
antipsychotic drugs can cause not only hyperglycemia, but can cause the emergence of
diabetes. Citrome et al. (2007) reviewed 25 studies of antipsychotic agents and concluded
that the second generation agents are not significantly less of a risk than first-generation
antipsychotic agents. Clearly, care must be taken when prescribing antidepressant and
antipsychotic medication to elders with diabetes.

Diabetes Self-Management Education
DSME is the foundation of treatment for diabetes and should occur as close to the
diagnosis as possible (Mensing et al., 2007). DSME has been shown to improve
glycemic control as well as decrease the chronic complications of diabetes (ADA, 2008).
Formal DSME usually consists of a week- long program from certified diabetes educators
(CDE) at an American Diabetes Association (ADA) certified center. ADA certification is
often required for insurance reimbursement (Powell, Glover, Probst & Laditka, 2005).
DSME provides an understanding of the pathophysiology of diabetes in lay terms,
teaches patients how to test their own blood sugar, and also highlights the importance of
care of their highly vulnerable feet. Healthy eating, exercise and weight management are
also stressed. Advanced education teaches insulin adjustment and carbohydrate counting.
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Despite the otherwise comprehensive nature of DSME, it has not traditionally included
screening for depression. DSME may be an ideal opportunity to assess depressive
symptomatology.

The Present Study
The present study assessed a community-dwelling population of elders with
diabetes using a survey developed for this project. The presence of depressive symptoms
was evaluated using the CES-D, a widely used and validated measure (Radloff, 1977).
The study assessed self-reported demographic variables, attitudes about diabetes and
control, and complications of diabetes. In addition the presence of comorbidities,
medication use and self-care behaviors in relation to depression diagnosis and symptoms
were also evaluated.
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CHAPTER III
Method
Introduction
The tremendous burden of diabetes in the elderly population has been
documented (CDC, 2007; Selvin et al., 2006; Stolk et al., 1997), and the connection
between diabetes and depression has been well-established (Anderson et al., 2001; Eaton
et al., 1996, Finkelstein et al., 2003). Many elders with diabetes and depression remain
undiagnosed and untreated, partly because current screening is inadequate (NIMH, 2007).
Diabetes Self-Management Education (DSME) is the foundation of diabetes therapy
(Mensing et al., 2007) and has been shown to decrease diabetes complications as well as
to increase well-being (Rubin, Peyrot & Saudek, 1989). DSME may be the ideal occasion
to assess elders with diabetes for depression.

Participants
The sampling frame for this study was a nonrandom convenience sample of adults
aged 55 or older receiving DSME services at Humphreys Diabetes Center (HDC) in
Boise, Idaho. Permission was obtained from the research committee of HDC to conduct
the study at this facility.
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Study Design
This is a nonexperimental, cross-sectional study. A cross-sectional approach
is appropriate for measuring prevalence or risk factors of a disease in a population and
when no study intervention is intended.

Measurement Tools
The study utilized a diabetes and depression survey instrument, the DD-S
(Appendix A). This instrument was constructed as the final project for the fall 2007
graduate seminar, Survey and Community-Based Research, at Boise State University.
DSME stresses the importance of self-care. Several items related to compliance
with diabetes self-care recommendations were queried with the DD-S. These included
frequency of: 1) blood sugar testing; 2) following a meal plan; 3) foot inspection; and 4)
exercise. Responses to these items were combined to create a compliance score for
purposes of analysis. This allowed each respondent to receive a single self-care
composite compliance score with a maximum of 16 points. Other constructs evaluated
with the DD-S included depression diagnosis and self-reported data including:
sociodemographic information, duration of diabetes, complications of diabetes, self-care
behaviors, comorbidities, and medication use.
In addition to completing the DD-S, each participant was asked to fill out the
CES-D (Appendix B), a self-administered depression instrument. The CES-D has been
widely used and validated and has a coefficient alpha of .85 (Radloff, 1977).
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DD-S Survey Validation
Face and content validity of this survey was assessed by a number of health care
professionals. With respect to construct validity, a high prevalence of depression was
hypothesized for the study population, and the instrument was evaluated for ability to
confirm this hypothesis. In addition, three separate questions on the survey associated
with depression diagnosis were assessed for correlation.

Procedures
The study was approved by the Institutional Review Board at Boise State
University.
The principal investigator is a previous Medical Director with longstanding
relationships with HDC staff. Contact was made with Judy Davis, R.N., program director
at HDC, and a copy of the study proposal was provided. After the protocol was approved
by the HDC Research Committee, survey packets were delivered to Ms. Davis. Ms.
Davis educated other HDC educators about the study and distributed survey packets to
DSME classes and to individual nurses and dieticians. Nurses and dieticians conducting
classes and individual consultations administered the survey packets to HDC clients.
Participants had type 2 diabetes, were aged 55 and older, and were receiving DSME
services. There were two distribution periods, the first from September 18 to October 5th
and the second from January 5th to the 31st. Study participation was offered to all ageappropriate clients during the two distribution periods. Surveys were administered at both
the Boise and Meridian HDC locations.
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The packet contained a recruitment/consent letter (Appendix C), a diabetes and
depression survey (DD-S – Appendix A) and a depression self-assessment instrument
(CES-D – Appendix B). All information obtained was confidential and identified by
protocol and participant numbers only. Study materials were kept in a cabinet in the
Health Sciences Riverside Building, Room 122A at Boise State University for the
duration of the study.

Statistical Analyses
The prevalence of depression was assessed via one of three methods: 1) by
frequency counts of those who self-reported a depression diagnosis; 2) those who selfreported taking an antidepressant on the medication list; and 3) those with a score of 16
or above on the CES-D. Participants from these three categories were combined into a
depression group for comparison to others in the study (the nondepression group).
A Mann Whitney test was used to compare the depression vs. nondepression
groups on a number of variables such as age, score on the composite compliance variable,
score on the CES-D, HA1c test score, number of medications and number of conditions.
A chi square test was used to assess the relationship between depression group
and other variables in the study such as gender, specific conditions and complications of
diabetes.
All data was analyzed using the Statistical Package for the Social Sciences
(SPSS). Statistical tests were two-tailed maintaining an overall α = .05 level of
significance.
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CHAPTER IV
Results
One hundred and fifty-three surveys were distributed to clients receiving diabetes
self-management education (DSME) at Humphreys Diabetes Center (HDC) in Boise,
Idaho. Twenty-six surveys were returned by mail for a 17% response rate.
This survey was presented to several health professionals and judged to have good face
and content validity. With respect to construct validity, a high prevalence of depression
was hypothesized for the study population, and the instrument confirmed this high
prevalence. In addition, there was complete correlation between self-reported diagnosis
of depression, reported treatments for depression and listed antidepressant medications.

Statistical Analyses
Of the 18 participants reporting their gender, 12 (67%) were female and 6 (33%)
were male. The mean age of the nineteen participants who reported their age was 66 (SD
= 4.98) with a range of 58 to 77. All but one participant reported their ethnicity, marriage
and financial status. All 25 (100%) of these were white. With respect to socioeconomic
status (SES), 17 (68%) reported their financial status as comfortable or very comfortable,
five (20%) reported just getting by and three (12%) reported not being able to make ends
meet. Twenty (80%) of participants were married. Of the 24 who reported information
about insurance status only one participant (4%) had no insurance.
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Table 1.
Demographic Data
Variables

Total number of participants
(% of total)

Gender (N = 18)
Female

12 (67%)

Male

6 (33%)

<65 years of age

9 (47%)

65 and over

10 (53%)

Age (N = 19)

Ethnicity (N = 25)
White

25 (100%)

African American

0 (0%)

American Indian

0 (0%)

Hispanic

0 (0%)

Asian/Pacific Islander

0 (0%)

Other

0 (0%)

Marital Status (N = 25)
Married or Partnered

20 (80%)

Divorced

2 (8%)

Separated

0 (0%)

Widowed

3 (12%)

19

Variables

Total number of participants
(% of total)
Single

0 (0%)

Other

0 (0%)

Financial Status (N = 25)
Very Comfortable

1 (4%)

Comfortable

16 (64%)

Just Getting By

5 (20%)

Can’t Make Ends Meet

3 (12%)

Insurance Status (N = 24)
Medicare Only

2 (8%)

Medicare/Medigap

12 (50%)

Medicaid

1 (4%)

No Insurance

0 (0%)

Private Insurance

8 (34%)

Veterans Administration

0 (0%)

Other

1 (4%)

Twenty-four (92%) participants were enrolled in a formal DSME program, and of
these, 20 (80%) were satisfied with the education provided. Eleven (42%) participants
had met with the nurse educator or dietician separately and nine (82%) of these were
satisfied with their care. Of the 11 (42%) who received brief education in the doctor’s
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office, seven (64%) were satisfied. One participant reported having had no diabetes
education.
Seventeen (65%) of the participants were diagnosed within one year of receiving
DSME services. The mean years duration of diabetes was 4.69 (SD = 7.51) with a range
from less than one year to 34 years. Fifteen (58%) reported that fear of medical
complications was the worst aspect of having diabetes, while seven (27%) were most
bothered by having to follow a meal plan. Only one (4%) participant cited cost as the
worst aspect of having diabetes.

Table 2.
DSME, Satisfaction, Time Since Diagnosis, and Worst Aspect of Having Diabetes
Variables

Total number of participants
(% of total)

DSME (N = 26)
Formal DSME

24 (92%)

Satisfied

20 (83%)

Not Satisfied

1 (4%)

No response

3 (13%)

Nurse or Dietician

11 (42%)

Satisfied

9 (82%)

Not Satisfied

2 (18%)

Brief doctor/nurse office Ed.

11 (42%)
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Variables

Total number of participants
(% of total)
Satisfied

7 (64%)

Not Satisfied

4 (36%)

No Diabetes Education

1 (4%)

Years since diagnosis (N = 25)
<5 years

18 (72%)

5 years or longer

7 (28%)

Worst aspect of diabetes (N = 26)
Fear of medical complications

15 (58%)

Following a meal plan

7 (27%)

Cost

1 (4%)

Other

3 (11%)

Diabetes management self-care behaviors were evaluated as presented in Table 3.
Almost two-thirds of the participants (65%) reported testing their blood sugar at home at
least two or more times per day. Eight (31%) participants checked their feet on a daily
basis and 10 (38%) checked at least two or more times per week. Eleven (42%)
participants followed a meal plan on a daily basis, while seven (27%) followed two or
more times per week. Exercise frequency was daily for six (23%) of the participants and
two or more times per week for 11 (42%). One participant was unable to exercise due to
severe neuropathy.
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Twenty participants reported a HA1c level and all testing was within the last six
months. The average was 7.7% (SD = 2.8%). Six (23%) either did not know what a HA1c
was or did not respond to the question.

Table 3.
Diabetes Care Self-Management Behaviors
Variables

Total number of participants
(% of total)

Blood Glucose Testing (N = 26)
Never

0 (0%)

Sometimes

2 (8%)

Daily

6 (23%)

Two or more times per day

17 (65%)

Can’t afford test strips

1 (4%)

Checking feet (N = 26)
Never

1 (4%)

Sometimes

7 (27%)

Two or more times per week

10 (38%)

Daily

8 (31%)

Follow Meal Plan (N = 26)
Never

1 (4%)

Sometimes

6 (23%)
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Variables

Total number of participants
(% of total)

Two or more times per week

7 (27%)

Daily

11 (42%)

Other

1 (4%)

Exercise (N = 26)
Never

2 (8%)

Sometimes

5 (19%)

Two or more times per week

11 (42%)

Daily

6 (23%)

Other

2 (8%)

Hemoglobin A1c (N = 21)
Mean HA1c (SD) Range

7.68 (2.81) (5.90-18.40)

Last HA1c test (N = 26)
Within 1 month

(61%)

Within 3 months

9 (35%)

Within 6 months

1 (4%)

Eight (31%) participants reported taking 0-4 medications, 11 (42%) reported
taking, 5-8, and seven (27%) reported taking 9-12 medications as illustrated in Figure 1.
Twelve (46%) participants reported daily aspirin use.
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Number of Medications
0 to 4

5 to 8

27%

9 to 12
31%

42%

Figure 1. Number of Medications

A wide variety of concomitant illnesses were reported by the participants. These
included high cholesterol (18; 69%), high blood pressure (18; 69%), obesity (13; 50%),
depression (9; 35%), other medical problems (7; 27%) and heart problems (5; 19%).
Complications of diabetes were asked about and are illustrated in Figure 2. Six
(23%) participants reported eye complications of diabetes, while 11 (42%) reported nerve
problems. Only one (4%) participant reported heart problems and two (8%) reported
circulation problems. No participant reported kidney problems.

Complications of Diabetes
50%
40%
30%
20%
10%
0%
Eye

Nerve

Heart

Figure 2. Complications of Diabetes

Circulation

Kidney
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Table 4.
Medication, Aspirin Use, Comorbidity, and Complications of Diabetes
Variables

Total number of participants
(% of total)

Number of Medications (N = 26)
0-4

8 (31%)

5-8

11 (42%)

9-12

7 (27%)

Other Medical Problems (N = 26)
High Cholesterol

18 (69%)

High Blood Pressure

18 (69%)

Obesity

13 (50%)

Depression

9 (35%)

Heart Problems

5 (19%)

Cancer

4 (15%)

Arthritis

4 (15%)

Lung Problems

3 (12%)

Anxiety

2 (8%)

Other

7 (27%)
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Variables

Total number of participants
(% of total)

Aspirin Use (N = 26)
Daily aspirin

12 (46%)

No aspirin

14 (54%)

Complications of Diabetes
(N = 26)
Nerve Problems

11 (42%)

Eye Problems

6 (23%)

Kidney Problems

0 (0%)

Heart Problems

1 (4%)

Circulation Problems

2 (8%)

Other

1 (4%)

None

5 (19%)

Table 5 reveals that only two (8%) participants were seeing an Endocrinologist
for their diabetes care, whereas most, or 18 (68%), were being cared for by their general
doctor. Two (8%) participants were seeing a nurse practitioner and two (8%) had no
current diabetes provider. Of the two that reported other sources of care, one (4%)
reported that Humphreys Diabetes Center was his or her diabetes provider.
Eight (31%) participants reported that their provider was very informed about diabetes,
six (23%) reported their provider was somewhat informed, and nine (34%) did not know.
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Table 5.
Diabetes Provider Information
Variables

Total number of participants
(% of total)

Diabetes Provider (N = 26)
Specialist (Endocrinologist)

2 (18%)

General Physician

6 (33%)

Nurse Practitioner

2 (8%)

No Current Diabetes Provider

2 (8%)

Other

7 (27%)

Provider Knowledge
Very Informed

8 (31%)

Somewhat Informed

6 (23%)

I Don’t Know

9 (34%)

Somewhat Uninformed

1 (4%)

Very Uninformed

0 (0%)

No Provider

2 (8%)

Antidepressant medications reported by participants included fluoxetine,
sertraline, duloxetine and trazadone. None of the participants reported taking third
generation antipsychotic medication, nor were anticholinergic medications listed. No
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participant in the study reported taking a medication for depression known to cause or
worsen diabetes.
Eight participants reported that they had been diagnosed with depression, and of
those, six (75%) were receiving medication therapy, one (12.5%) was receiving
psychotherapy, and one (12.5%) was being treated with both modalities. Of those being
treated for depression, two (25%) scored above 16 on the CES-D. One of those
participants reported taking fluoxetine, and the other was not on an antidepressant. In
addition, four (22%) who had not previously been diagnosed with depression also had
significant depressive symptomatology on the CED-S. A total of 12 (46%) participants
either had a previous diagnosis of depression or a positive score on the CES-D, and these
12 comprised the depression group for purposes of analysis.
Among the 18 participants who reported their gender, nine were classified in the
depression group. Of these, eight (88.8%) were women. Women were thus found to be
significantly more likely to be depressed or have a diagnosis of depression than men,
χ2(1, N = 18) = 4.27, p ≤ .05.
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Gender Distribution of
Depressed Group
11.20%

Male
Female

88.80%

Figure 3. Gender Distribution of Depression Group

Table 6.
Depression Data
Variables

Total number of participants
(% of total)

Diagnosis of depression (N = 26)
Yes

8 (31%)

No

18 (69%)

Treated for depression (N = 8)
Normal CES-D

6 (75%)

Depressive CES-D

2 (25%)

Therapies for Depression (N = 8)
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Variables

Total number of participants
(% of total)
Medication

6 (74%)

Psychotherapy

1 (13%)

Medication and Psychotherapy

1 (13%)

No depression diagnosis (N = 18)
Normal CES-D

14 (78%)

Depressive CES-D

4 (22%)

Mann-Whitney tests were performed comparing the depression and nondepression
groups with respect to age, HA1c score, CES-D score, composite compliance score,
number of conditions, number of medications and years with diabetes.

Table 7
Mann-Whitney Test Results for Depression versus Nondepression Group
Depression

Nondepression

Mann-Whitney

Mean

Median

N

Mean

Median

z

p

Medications 12

8.33

9.5

14

3.71

3.5

-3.16

0.002

CES-D

11

15.36

17

13

4.54

3

-3.57

0.001

Conditions

12

4.42

5.5

14

2.5

2

-1.91

0.056

HA1c

8

6.95

6.85

13

8.13

7.2

-0.29

0.772

Compliance

12

12.08

13

14

12.71

14

-0.73

0.466

Variable

N
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Number of conditions, HA1c value, compliance score, age and years with
diabetes were not significantly different between depression and nondepression groups.
The self-reported number of medications were significantly higher in the depression than
nondepression group (z = -3.16, p = .002). Number of medications and number of
conditions were highly correlated r(26) = .57 p ≤ .01. Score on the CES-D was
significantly higher in the depression compared to the nondepression group (z = -3.57, p
= .001). Those with complications of diabetes were not found to have had a significantly
longer duration of diagnosed diabetes or a difference in age.
Chi square analysis revealed that those in the depression group were no more
likely to have high cholesterol, high blood pressure, obesity, heart problems, lung
problems, cancer or anxiety, compared to those in the nondepression group. Similarly,
none of the complications of diabetes such as eye, nerve, heart or circulation problems
were more frequent in the depression group.
There was no difference between depression versus nondepression groups with
respect to marital status or fear of medical complications from diabetes. Although twice
as many in the nondepression group (64.7%) compared to the depression group (35.3%)
were financially comfortable, financial status was not predictive of depression group.
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CHAPTER V
Discussion
The overall rate of response to this survey was low, but approximates typical rates
for mail-in surveys (Neutens & Rubinson, 2002). There is no reason to believe there was
response bias to this survey. Although the stigma of depression may have led some
clients not to participate, it is speculative whether those with or without depression would
have been more or less likely to participate.
The most important finding of this study is the extremely high prevalence of
depression in this group of community dwelling elders with diabetes. Nearly half (46%)
of study participants had a diagnosis of depression and/or scored positively on the CESD. Though prevalence data is not available specifically on elder adults with diabetes,
previous estimates of depression in all adults with diabetes is stated to be about 30%
(Anderson et al., 2001). Twenty-five percent of those with a positive CES-D in this study
were previously undiagnosed with depression, and 25% of those under treatment for
depression were still symptomatic. Clearly, better screening for depression is needed in
elders with diabetes, and when depression is treated, better follow-up is needed for this
insidious condition.
No study participant was found to be taking a medication for depression that is known to
cause or worsen type 2 diabetes. All antidepressants used by participants in this study
were in the class of selective serotonin reuptake inhibitors. This class of antidepressants
is usually effective and well-tolerated in the elderly (Lustman et al., 2000).
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A further important finding from this study is that depression in the elder with
diabetes is significantly related to the number of medications taken. As number of
medications is highly correlated with number of medical conditions, number of
medications alone may be a simple measure with which to estimate burden of disease.
Number of medications as a factor associated with depression in diabetes has not been
previously reported and may be useful in identifying a high-risk subgroup.

Number of Medications
14
12
10
8

Medications

6

Conditions

4
2
0
1

3

5

7

9 11 13 15 17 19 21 23 25

Figure 4. Medications and Conditions

No specific medical condition was associated with being in the depression group,
nor was any specific complication of diabetes found with significantly greater frequency
in this group. In previous studies heart disease has been so highly associated with
depression that screening for depression is now recommended for all those with heart
disease (Lichtman et al., 2008). Only five participants in this study reported heart disease,
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and failure to find an association with depression is most likely related to such a small
sample size.
Obesity has previously been shown to increase the risk of adult depression (Simon
et al., 2006). Half of the people in the study reported being obese; however, obesity was
no more common in the depression group than the nondepression group. It is possible
that elders differ from other adults with respect to this variable and further study of this
issue seems warranted.
Female gender is a well-known risk factor for depression (Cole & Dendukuri,
2003). This study suggests that the depression risk is even higher in the elderly female
with diabetes than in other adult females. Previous studies have found a 2:1 female to
male prevalence of depression (CDC, 2007); however, in this study, almost all of those in
the depression group were female. Additionally, the two participants with a previous
diagnosis of depression who were still symptomatic were both female. The reasons for
gender differences in depression are not known; however, this knowledge may help
inform future depression screening and treatment efforts.
This study did not show a relationship between depression and diabetes care
compliance behaviors, as has previously been reported (Ciechanowski, Katon & Russo,
2000). It is likely that this is an artifact of participants being studied at a diabetes
education center, where compliance and control are strongly emphasized. It may also
relate to the relatively recent onset of diabetes diagnosis in this sample, as self-care
behaviors may wane over time.
Similarly, diabetes control, as measured by HA1c, was not worse in the
depression group than in the nondepression group. The overall average HA1c of all study
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participants of 7.68 is remarkably low. Despite this excellent control, several participants
did report complications of diabetes. It may be that participants had higher glucose levels
at other times in the course of their illness, even prior to diagnosis. It is known that half
of those with diabetes in this country remain undiagnosed, and many with diabetes may
have the disease for up to 15 years before a clinical diagnosis is made (CDC, 2007).
Of no relation to depression, but of definite concern, is that only 46% of
participants were taking daily aspirin. Those with diabetes are considered to have as high
a risk for coronary disease as those who have had a previous myocardial infarction, and it
recommended that all patients with diabetes take daily aspirin prophylaxis (ADA, 2008).
This simple intervention could be life-saving for elders with diabetes. Almost all
participants in this study were being followed for their diabetes in the primary care
setting. It would seem greater education of primary care physicians regarding this issue is
warranted.

Limitations
The primary limitation of this study is the small sample size. Failure to provide
training and/or a written script to diabetes educators responsible for recruitment was a
definite oversight and may have fostered low participation. In addition, the homogeneity
of the participants with respect to ethnicity and financial status makes the results of the
study less generalizable. Elders with diabetes receiving DSME services may be different
in other ways from elders with diabetes in the community.
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Conclusions
The high prevalence of depression found in this study lends support for regular
depression screening of all elders with diabetes. The findings from this study further
suggest that females and those with high comorbidity are at particular risk. These
subgroups may need to be screened more often. In addition, this study underscores the
need for regular assessment of the effectiveness of depression treatment.
The goal of DSME is to enable patients to control, care for and cope with
diabetes. Untreated depression thwarts all of these efforts (Black, Markides, & Ray,
2003) and may make DSME much less effective. Fortunately, patients are often referred
for DSME early after the diagnosis of diabetes, as was seen in this study. These factors
indicate that DSME is an ideal occasion to screen for depression. The DD-S in
combination with the CES-D, administered during DSME, was a very effective way to
screen for depression in elders with diabetes. Such screening would promote early
detection and treatment of depression. This could lead to improved quality of life
(Jackson, DeZee & Berbano, 2004) and better outcomes for elders with diabetes (Bogner,
Morales, Post & Bruce, 2007).

Directions for Further Investigation
Further validation of the DD-S survey instrument is needed. Utilization of the
survey in a clinic setting with comparison to the medical record would provide criterion
validity. Comparison of reported HA1c to that measured during DSME would be
similarly informative.
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To confirm that the results of this study can be generalized, especially the high
prevalence of depression, it is important to study a community sample of elders with
diabetes who are not receiving DSME services.
With a larger sample size, differences between the depression and nondepression
group with respect to compliance score, obesity, and heart disease may be revealed.
Power analysis reveals that 74 more participants would be needed to more fully evaluate
these issues.
Key stakeholders such as the HDC Research Committee, Board of Directors and
staff will be presented the results of this study. The most exciting possibility for further
research would be to incorporate the study surveys into regular DSME programs for an
extended study period. Stakeholder counsel and support will be invaluable to the next
phase of study.

38

REFERENCES
American Diabetes Association. (2008). Diabetes statistics. Retrieved March 6, 2009.
http://www.diabetes.org/diabetes-statistics.jsp
Ancelin, M. L., Artero, S., Portet, F., Dupuy, A., Touchon, J., & Ritchie, K. (2006). Nondegenerative mild cognitive impairment in elderly people and use of
anticholinergic drugs: Longitudinal cohort study. British Medical Journal, 332,
455-459.
Anderson, R. J., Clouse, R. E., Freedland, K. E., & Lustman, P. J. (2001). The prevalence
of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care,
24, 1069-1078.
Ayalon, L., Arean, P. A., & Alvidrez, J. (2005). Adherence to antidepressant medications
in Black and Latino elderly patients. American Journal of Geriatric Psychiatry,
13, 572-580.
Bell, R. A., Smith, S. L., Arcury, T. A., Snively, B. M., Stafford, J. M., & Quandt, S. A.
(2005). Prevalence and correlates of depressive symptoms among rural older
African Americans, Native Americans, and Whites with diabetes. Diabetes Care,
28, 823-829.
Black, S. A., Markides, K. S., & Ray, L. A. (2003). Depression predicts increased
incidence of adverse health outcomes in older Mexican Americans with type 2
diabetes. Diabetes Care, 26, 2822-2828.

39
Borchelt, M. (1995). Potential side-effects and interactions in multiple medication in
elderly patients: Methodology and results of the Berlin Study of Aging. Zietschrift
fur Gerontologie und Geratrie, 28, 420-428.
Bogner, H. R., Morales, K. H., Post, E. P., & Bruce, M. L. (2007). Diabetes, depression
and death: A randomized controlled trial of depression treatment program for
older adults based in primary care (PROSPECT). Diabetes Care, 30, 3005-3010.
Centers for Disease Control and Prevention. (2007). Diabetes: Disabling disease to
double by 2050. Retrieved November 6, 2007 from http://www.cdc.gov/ nccdphp/
publications/aag/ddt.htm
Chau, D. L., Shumaker, N., & Plodkowski, R.A. (2005). Complications of type 2 diabetes
in the elderly. Geriatric Times, IV, retrieved November 7, 2007 from
http://www.cmellc.com/ geratrictimes/g030411
Ciechanowski, P. S., Katon, W. J., & Russo, J. E. (2000). Depression and diabetes:
Impact of depressive symptoms on adherence, function and costs. Archives of
Internal Medicine, 160, 3278-3285.
Citrome, L. L., Holt, I. G., Zachry, W. M., Clewell, J. D., Orth, P. A., Karaglanis, J. L.,
et al. (2007). Risk of treatment-emergent diabetes mellitus in patients receiving
antipsychotics. Annals of Pharmacotherapy, 41, 1593-1603.
Cole, M. G., & Dendukuri, H. (2003). Risk factors for depression among elderly
community subjects: A systematic review and meta-analysis. American Journal of
Psychiatry, 160, 1147-1156.

40
DeGroot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001).
Association of depression and diabetes complications: A meta-analysis.
Psychosomatic Medicine, 63, 619-630.
Eaton, W. E., Armenian, H., Gallo, J., Pratt, L., & Ford, D. E. (1996). Depression and
risk of onset of type II diabetes: A prospective population-based study. Diabetes
Care, 20, 1097-1102.
Finkelstein, E. A., Miller, K., Bray, J. W., Tompkins, C., Chen, H., Keme, A., et al.
(2003). Prevalence and costs of major depression among elderly claimants with
diabetes. Diabetes Care, 26, 415-420.
Goldney, R. D., Fisher, L. J., Phillips, P. J., & Wilson, D. H. (2004). Diabetes,
depression, and quality of life: A population study. Diabetes Care, (27),
1066-1070.
Gregg, E. W., & Brown, A. (2003). Cognitive and physical disabilities and aging-related
complications of diabetes. Clinical Diabetes, 21, 113-118.
Hitner, H., & Nagle, B. (2005). Geriatric pharmacology. Pharmacology, An Introduction
(pp. 30-39). New York: McGraw Hill.
Hobbs, F. B. (2001). The elderly population. U. S. Census Bureau. Retrieved November
8, 2007 from http://www.census.gov/population/www/pop-profile/elderpop.html
Jackson, J. L., DeZee, K., & Berbano, E. (2004). Can treating depression outcomes
improve disease outcomes? Annals of Internal Medicine, 140, 1054-1056.
Katon, W. J., Ciechanowski, P., Rutter, C., Kinder, L., Simon, G., Young, B., et al.
(2005). The association of comorbid depression with mortality in patients with
type 2 diabetes. Diabetes Care, 28, 2668-2675.

41
Kawakami, N., Shimizu, H., Takatsuka, N., & Ishibashi, H. (1999). Depressive
symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes
Care, 22, 1071-1076.
Koller, E. A., Cross, M. S., Doraiswamy, M., & Schneider, B. S. (2003). Risperadoneassociated diabetes mellitus: A pharmacovigilance study. Pharmacotherapy, 23,
735-744.
Lichtman, J. H., Bigger, T., Blumenthal, J. A., Frasure-Smith, N., Kaufman, P. G.,
Lesperance, F., et al. (2008). Depression and coronary heart disease:
Recommendations for screening, referral and treatment. Circulation, 118, 17681775.
Lustman, P.J., Freedland, K.E., Griffith, L. S. & Clouse, R.E. (2000). Fluoxetine for
depression in diabetes: A randomized double-blind placebo-controlled trial.
Diabetes Care, 23, 618-623.
Lustman, P .J., Griffith, L. S., Clouse, R. E., Freedland, K. E., Eisen, S. A., Rubin, E. H.,
et al. (1997). Effects of nortriptyline on depression and glycemic control in
diabetes: Results of a double-blind, placebo-controlled trial. Psychosomatic
Medicine, 59, 241-250.
Mensing, C., Boucher, J., Cypress, M., Weinger, K., Mulcahy, K., Barta, P., et al. (2007)
National standards for diabetes self-management education. Diabetes Care, 30,
S96-S103.
Mojtabal, R., & Olfson, M. (2003). Medication costs, adherence, and health outcomes
among Medicare beneficiaries. Health Affairs, 22, 220-229.

42
National Institute of Mental Health. (2007). Older adults: Depression and suicide facts.
Retrieved November 6, 2007 from http://www.nimh.nih.gov/ health/ publications/
older-adults-depression-and-suicide-facts.shtml
Neutens, J. J. & Rubinson, L. (2002). Research techniques for the health sciences. San
Francisco: Benjamin Cummings.
Papadopoulos, A. A., Kontodimopoulos, N., Frydas, A., Ikonomakis, E., & Niakas, D.
(2007). Predictors of health-related quality of life in type II diabetic patients in
Greece. BMC Public Health, 7. Retrieved October 1, 2007, from http://
www.biomedcentral.com
Polonsky, W. H. (2000). Understanding and assessing diabetes-specific quality of life.
Diabetes Spectrum, 13, 36-48.
Powell, M. P., Glover, S. H., Probst, J. C., & Laditka, S. B. (2005). Barriers associated
with the delivery of Medicare-reimbursed diabetes self-management education.
The Diabetes Educator, 31, 890-899.
Radloff, L. S. (1977). The CES-D scale: A self report depression scale for research in the
general population. Applied Psychological Measurement, 1, 385-390.
Robbins, J. M., Webb, D. A., & Sciamanna, C. N. (2005). Cardiovascular comorbidities
among public health clinic patients with diabetes: the Urban Diabetics Study.
BMC Public Health, 15. Retrieved December 5, 2007, from http://www.
Biomedcentral.com
Rubin, R. R., Peyrot, M., & Saudek, C. D. (1989). Effect of diabetes education on
self-care, metabolic control, and emotional well-being. Diabetes Care, 12,
673-679.

43
Schoevers, R. A., Smit, F., Deeg, D. J., Cuijpers, P., Dekker, J., van Tillburg, W., et al.,
(2006). Prevention of late-life depression in primary care: Do we know where to
begin? The American Journal of Psychiatry, 163, 1611-1621.
Selvin, E., Coresh, J., & Brancati, F. L. (2006). The burden and treatment of diabetes in
elderly individuals in the U.S. Diabetes Care, 29, 2415-2419.
Simon, G. (2003). Social and economic burden of mood disorders. Biologic Psychiatry,
54, 208-215.
Simon, G. E., Von Korff, M., Saunders, K., Miglioretti, D. L., Crane, P. K., van Belle,
G., et al., (2006). Association between obesity and psychiatric disorders in the US
adult population. Archives of General Psychiatry, 63, 824-830.
Stolk, R. P., Pols, H. A.., Lamberts, S. W. J., de Jong, P. T., Hofman, A., & Grobbee, D.
E. (1997). Diabetes mellitus, impaired glucose tolerance, and hyperinsulinemia in
an elderly population: The Rotterdam Study. American Journal of Epidemiology,
145, 24-32.
World Health Organization. (2007). Gender and women’s health. Retrieved November 6,
2007 from http://www.who.int/mentalhealth/prevention/gender
Wild, S., Sicree, R., Roger, G., King, H. & Green, A. (2004). Global prevalence of
diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27,
1047-1053.

44

APPENDIX A
DD-S, Diabetes and Depression Survey
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DD-S
Q1. When were you diagnosed with diabetes?

_____year

Q2. What is the worst aspect of having diabetes?
(Please circle your answer)
1.
2.
3.
4.

Fear of complications
Following a meal plan
Cost of medical care and supplies
Other________________________

Q3. What sort of diabetes education have you completed?
(Circle the one answer that most closely describes your experience)
1. Formal program or classes at a diabetes center
2. Met with the nurse educator and/or dietician
separately
3. Brief education from my doctor and/or his or her
nurse
4. None
Q4. How satisfied or dissatisfied were you with your educational
experience?
Very

Very

Dissatisfied
1

Satisfied
2

3

4

5

For the next four questions, please refer to your habits over the last
month:
Q5. Do you test your blood sugar at home?
1. Never
2. Sometimes
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3. Daily
4. Two times per day or more
5. Other___________________
Q6. Do you check your feet?
1.
2.
3.
4.
5.

Never
Sometimes
Twice a week
Daily
Other________________

Q7. Do you follow a meal plan?
1.
2.
3.
4.
5.

Never
Sometimes
Twice a week
Daily
Other________________

Q8. Do you exercise?
1.
2.
3.
4.
5.

Never
Sometimes
Twice a week
Daily
Other________________

Q9. Whom do you see for your diabetes care?
1.
2.
3.
4.

Diabetes Specialist (Endocrinologist)
General Doctor (Internist or Family Practitioner)
Nurse Practitioner or Physician Assistant
Other_______________________________

Q10. How satisfied or dissatisfied are you with your diabetes care?
Very

Very
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Dissatisfied
1

Satisfied
2

3

4

5

Q11. When was your last A1C test?___Month___Year__Do not know
Q12. What was your last A1C value _______ %________Do not know
Q13. Please list your medications:
_____________________
_____________________
_____________________

______________________
______________________
______________________

_____________________
_____________________

______________________
______________________

_____________________

______________________

Q14. Do you take an aspirin every day?

____ Yes____No

Q15. Do you have any complications of your diabetes?

Yes

No

Eye problems (cataracts, glaucoma, blindness)

1

2

Nerve problems (burning, numbness, tingling)

1

2

Kidney problems (dialysis, transplant)

1

2

Heart problems (angina, heart attack)

1

2

Circulation problems (stroke, loss of limb)

1

2

Other________________________________

Now there will be just a few questions about depression:
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Q16. There are many challenges to living with diabetes. Have you
ever been diagnosed with depression?
______Yes______No
If No, skip to Question 18.
Q17. What treatment have you had for depression?
1.
2.
3.
4.

No treatment
Psychotherapy
Medication
Psychotherapy and Medication

The next five questions ask some personal information. All responses
will be kept confidential:

Q18. When were you born?

_______Month_______Year

Q19. What is your gender?
1. Male
2. Female
Q20. What sort of insurance do you have?
1.
2.
3.
4.

Medicare only
Medicare and Medigap or other supplement
Medicaid
No insurance

Q21. Please rate your financial status:
1. Comfortable
2. Very Comfortable
3. Just getting by
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4. Can’t make ends meet
Q22. Which of the following best describes your racial or ethnic
identification?
1. White (Caucasian)
2. African American
3. Hispanic
4. Native American/American Indian
5. Asian or Pacific Islander
6. Other (please specify)________________________
Q25. What is your marital status?
1.
2.
3.
4.
5.
6.
7.

Married
Divorced
Separated
Widowed
Never Married or Partnered
Single
Partnered

Please make any further comments you may have about the topics in
this survey:
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Thank you very much for participating in this important survey. All
of your answers will remain anonymous and will be used for
research purposes only.
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APPENDIX B
CES-D, Self-Assessment Instrument for Depression
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The CES-D

There are restrictions to copying this instrument.
It may be found at: http://www.chcr.brown.edu/pcoc/cesdscale.pdf
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APPENDIX C
Letter of Recruitment and Consent to the Study
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January 5, 2009
Dear Volunteer,
A group of faculty and student researchers at Boise State University are conducting a
study of type 2 diabetes. Specifically, we are interested in knowing more about the
diabetes self-management education you have received.
Attached to this letter you will find two documents. The first is a diabetes survey, the
DD-S. This survey asks questions about how long you have had diabetes, diabetes
education, complications and control. There are also a few questions related to
depression. This survey also asks demographic information. Due to the make-up of
Idaho’s population, the combined answers to these questions may make an individual
person identifiable. We will make every effort to protect your confidentiality. However,
if you are uncomfortable answering any of these questions, you may leave them blank
and complete the rest of the survey.
The second document, the CES-D, is a brief questionnaire that asks questions about your
mood. This tool is not for diagnostic purposes and the results will not be shared with
anyone outside the study. Both of these questionnaires are confidential and we ask that
you not put your name or any other identifying information on them. Completion of both
items will take approximately thirty minutes.
When you have completed both items, you may simply return them to us in the selfaddressed postage-paid envelope that came in the same package as the DD-S and the
CES-D. We ask that you return the envelope no later than January 30, 2009.
We certainly hope that you will consider completing these surveys, as your answers will
provide important information about diabetes education and treatment. If you have any
questions regarding the study, please do not hesitate to contact me at (208) 371-6787.
Sincerely,

Cynthia Clinkingbeard, MD
Student, Master of Health Science Program
College of Health Sciences
Boise State University

